Abstract:Until the 1990s, most therapeutic trials in gastroesophageal reflux disease (GERD) focussed upon endoscopic lesions. In fact the correlation between patient symptoms and both the presence and grade of esophagitis is very poor. The classical criteria for the assessment of therapeutic efficacy in GERD have therefore been revised, and there is now a consensus that the relief of symptoms and the long-term control of the disease are the primary aims of therapy for the majority of patients. Proton pump inhibitors (PPIs) represent the mainstay of therapy for patients with non-erosive reflux disease (NERD) as well as esophagitis. Although a stepwise strategy has been recommended in the past, a step-down strategy (starting with a full-dose PPI) appears to be a more cost-effective approach. There are as yet insufficient data to establish the clear superiority of one PPI over others. PPIs have a number of limitations. Symptom relief is significantly inferior in NERD than in erosive esophagitis. The heterogeneity of the NERD group may be one of the most influential factors, but the role of esophageal hypersensitivity has been suggested especially in patients with normal acid exposure. The role of non-acid reflux should also be scrutinized. Long-term control of the disease can be achieved by drug therapy, anti-reflux surgery and now with a variety of endoscopic procedures. The different drug management strategies can be divided into (i) continuous maintenance therapy and (ii) discontinuous therapy which can again be divided into two categories, intermittent and on-demand drug therapy. A case-by-case approach is recommended to determine the personal therapeutic needs and preferences of each individual. Many patients with NERD or mild esophagitis do not require continuous maintenance therapy and recent studies have shown excellent results with different PPI on-demand therapy regimens. Finally when making a choice between different long-term strategies both the clinician and the informed patient have to consider efficacy, safety, tolerability and cost. The potential efficacy of new drugs, especially the GABA(B) agonists and the fast onset acid suppressors, as well as the cost-effectiveness of non-drug strategies (surgery and endoluminal therapies) should be further evaluated.

Gastroesophageal Reflux Disease: New Insights and Treatment Approaches

Current Advances in Diagnosis, Therapeutics, and Surgical Interventions for the Management of Refractory Gastroesophageal Reflux Disease (GERD): An Update

Endoscopic Advances in the Diagnosis and Management of Gastroesophageal Reflux Disease

Current Trends in the Management of Gastroesophageal Reflux Disease

Epidemiology, Causes, and Management of Gastro-esophageal Reflux Disease: A Systematic Review

Innovative therapeutic strategies in the treatment of gastroesophageal reflux disease (GERD): A review of progress and perspectives

Diagnosis and Treatment of Gastroesophageal Reflux Disease: Report of 1014 Cases

Gastroesophageal reflux disease: A clinical overview for primary care physicians

Refractory Gastroesophageal Reflux Disease: Diagnosis and Management

Non-Acid GERC: Pathogenesis, Diagnosis and Management

Gastroesophageal reflux disease: recent innovations in endoscopic assessment and treatment.

Current advances in the diagnosis and management of gastroesophageal reflux disease

Diagnosis of gastroesophageal reflux: an update on current and emerging modalities

An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease

The Medical Management of Gastroesophageal Reflux Disease: A Narrative Review

Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment

The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions

Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management

Treatment of Gastroesophageal Reflux Disease in Adults: An Individualized Approach

Interactions Between Gastroesophageal Reflux Disease and Diabetes Mellitus: A Systematic Review of Pathophysiological Insights and Clinical Management Strategies

Gastroesophageal reflux disease: risk factors, current possibilities of diagnosis and treatment optimisation